Lindbrook Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $533 | Buy |
+67
| New | +$533 | ﹤0.01% | 2611 |
|
|
2024
Q3 | – | Sell |
-459
| Closed | -$4.99K | – | 2901 |
|
|
2024
Q2 | $4.99K | Buy |
459
+261
| +132% | +$2.84K | ﹤0.01% | 1993 |
|
|
2024
Q1 | $3.71K | Hold |
198
| – | – | ﹤0.01% | 2030 |
|
|
2023
Q4 | $4.29K | Sell |
198
-80
| -29% | -$1.73K | ﹤0.01% | 1963 |
|
|
2023
Q3 | $5.72K | Buy |
278
+214
| +334% | +$4.4K | ﹤0.01% | 1705 |
|
|
2023
Q2 | $3.01K | Buy |
64
+12
| +23% | +$564 | ﹤0.01% | 1999 |
|
|
2023
Q1 | $2.18K | Sell |
52
-4
| -7% | -$168 | ﹤0.01% | 2207 |
|
|
2022
Q4 | $2.14K | Sell |
56
-177
| -76% | -$6.75K | ﹤0.01% | 2204 |
|
|
2022
Q3 | $9K | Buy |
+233
| New | +$9K | ﹤0.01% | 1387 |
|
|
2022
Q2 | – | Sell |
-73
| Closed | -$2K | – | 2758 |
|
|
2022
Q1 | $2K | Buy |
+73
| New | +$2K | ﹤0.01% | 2073 |
|
|
2021
Q4 | – | Sell |
-55
| Closed | -$2K | – | 2195 |
|
|
2021
Q3 | $2K | Buy |
55
+15
| +38% | +$545 | ﹤0.01% | 1597 |
|
|
2021
Q2 | $2K | Sell |
40
-12
| -23% | -$600 | ﹤0.01% | 1637 |
|
|
2021
Q1 | $4K | Hold |
52
| – | – | ﹤0.01% | 1350 |
|
|
2020
Q4 | $4K | Hold |
52
| – | – | ﹤0.01% | 1276 |
|
|
2020
Q3 | $3K | Hold |
52
| – | – | ﹤0.01% | 1306 |
|
|
2020
Q2 | $2K | Buy |
+52
| New | +$2K | ﹤0.01% | 1430 |
|